Connect with us

Crypto World

Centene (CNC) Stock Plunges 14% as CEO Warns of Massive ACA Enrollment Decline

Published

on

CNC Stock Card

TLDR

  • Shares of Centene plummeted 14% Tuesday, claiming the title of S&P 500’s biggest loser for the session
  • Membership in ACA programs projected to decline to 3.5 million members by Q1 conclusion, a steep fall from December’s 5.5 million
  • Management stood by its 2026 adjusted EPS forecast of above $3
  • Mizuho Securities downgraded its price objective from $47 down to $41 while keeping a Neutral stance
  • Medicare Advantage operations continue to operate at a loss and won’t reach profitability until after 2026

Investors in Centene have experienced a turbulent 2026, and Tuesday’s trading session only amplified the pain. The managed care provider’s shares tumbled 14% following remarks made by CEO Sarah London during her presentation at the Barclays Global Healthcare Conference, where her disclosure about plunging enrollment figures sent shockwaves through the market.


CNC Stock Card
Centene Corporation, CNC

During her presentation, London informed conference participants that all three primary business segments at Centene continue to perform in line with 2026 projections. She confirmed the company’s adjusted earnings forecast of more than $3 per share — a figure that aligns precisely with the $3 consensus among analysts tracked by FactSet.

However, the market response was far from positive. With the guidance failing to deliver any upward revision, market participants focused their attention on the troubling membership trends.

The health insurer now projects ACA marketplace enrollment will sink to 3.5 million by the conclusion of the first quarter, representing a dramatic decrease from the 5.5 million members it had in December. As of the most recent February data, enrollment stood at 3.6 million participants.

London revealed that company leadership had predicted the overall marketplace would contract “somewhere between the high teens and the mid-thirties” on a percentage basis. She noted Centene anticipated finishing “at the higher end of that and possibly higher than the top end of that.”

Advertisement

She explained that some of the membership decline stems from strategic pricing adjustments implemented at year’s start, where the company chose to emphasize profitability enhancement rather than expanding its member base.

Medicare Advantage Still a Drag

The Medicare Advantage segment at Centene remains a significant headwind for overall performance. Profitability in this division was negative throughout 2025 and is projected to stay marginally unprofitable during 2026, with management targeting break-even status by 2027.

Adding to market uncertainty is the pending final rate announcement from the Centers for Medicare and Medicaid Services, scheduled for release by April 6 at the latest. The Trump administration’s earlier proposal to maintain essentially flat Medicare reimbursement rates for 2027 triggered widespread selling in Centene shares and throughout the managed care sector.

London disclosed that Centene had filed formal commentary with CMS regarding the Advance Rate Notice and voiced optimism that the final rate schedule would more appropriately account for current medical cost inflation trends affecting the entire industry.

Advertisement

Analyst Reaction

Mizuho responded swiftly following the conference presentation. The investment firm reduced its price objective on Centene shares to $41 from the previous $47 while maintaining its Neutral rating.

Mizuho pointed to worries surrounding health insurance marketplace attrition and specialty pharmaceutical cost pressures. The firm indicated it would employ a more cautious valuation approach until greater visibility emerges regarding the ultimate severity of the enrollment deterioration.

Truist Securities adopted a more constructive perspective, preserving its Buy recommendation with a $49 price objective, highlighting margin expansion potential and confidence from executive leadership. Cantor Fitzgerald maintained its Neutral position with a $41 target, characterizing the 2026 operating landscape as difficult.

For perspective, Centene shares have declined 9.7% during 2026, compared to a modest 0.7% pullback for the broader S&P 500 index.

Advertisement

Despite the selloff, the stock has actually outperformed several competitors. Molina Healthcare has retreated 17% year-to-date, Elevance Health is off 18%, and UnitedHealth Group has lost 14%.

Centene’s fourth quarter 2025 results revealed an adjusted diluted loss per share of $1.19, which marginally surpassed expectations for a $1.22 loss. Total revenue reached $49.73 billion, exceeding the anticipated $48.39 billion.

InvestingPro estimates Centene’s fair value at $62.11, with Wall Street analysts forecasting full-year 2026 EPS of $3.05.

Advertisement

Source link

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Crypto World

Scaling AI Makes It Riskier

Published

on

Scaling AI Makes It Riskier

Opinion by: Mohammed Marikar, co-founder at Neem Capital

Artificial intelligence has consistently been defined by scale, so far — bigger models, faster processing, expanding data centers. The assumption, based on traditional technology cycles, was that scale would keep improving performance and, over time, costs would fall and access would expand.

That assumption is now breaking down. AI is not scaling like other software. Instead, it is capital-intensive, constrained by physical limits, and hitting diminishing returns far earlier than expected.

The numbers make this clear. Electricity demand from global data centers will more than double by 2030 — levels once associated with entire industrial sectors. In the US alone, data center power demand is projected to rise well over 100 percent before the decade ends. This expansion is demanding trillions of dollars in new investment alongside major expansions in grid capacity.

Advertisement

Meanwhile, these systems are being embedded into law, finance, compliance, trading and risk management, where errors propagate quickly but credibility is non-negotiable. In June 2025, the UK High Court warned lawyers to immediately stop submitting filings that cited fabricated case law generated by AI tools.

The scaling AI debate

When an AI system can invent a precedent that never existed, and a professional relies on it, debates about scaling start becoming serious questions of public trust. Scaling is amplifying AI’s weaknesses rather than solving them.

Part of the problem lies in what scale actually improves. Large language models (LLMs) are evolving to become increasingly fluent because language is pattern-based. The more examples an LLM sees of how real people write, summarize and translate, the faster it improves.

Deeper intelligence — reasoning — does not scale the same way. The next generation of AI must understand cause and effect and know when an answer is uncertain or incomplete. It will need to explain why a conclusion follows, not simply produce a confident response. This does not reliably improve with more parameters or more compute.

Advertisement

The consequence is a growing verification burden. Humans must spend more time checking machine output rather than acting on it, and that burden builds as systems are deployed more widely.

The cost of training AI models

Training frontier AI models has already become extraordinarily expensive, with credible tracking suggesting costs have been multiplying year over year, and projections that single training runs could soon exceed $1 billion. Training is only the entry cost.

The larger expense is inference: running these models continuously, at scale, with real latency, uptime and verification requirements. Every query consumes energy. Every deployment requires infrastructure. As usage grows, energy use and costs compound.

In terms of markets and crypto, AI systems are increasingly used to monitor onchain activity, analyze sentiment, generate codes for smart contracts, flag suspicious transactions and automate decisions.

Advertisement

In such a fast-moving, competitive environment, fluent but unreliable AI propagates errors quickly; false signals move capital, and fabricated explanations and hallucinations undermine trust. One example of this is false positives being generated in automated Anti-Money Laundering (AML) flagging, a common issue that wastes time and resources on investigating innocent trading activity.

Time to improve reasoning

Scaling AI systems without improving their reasoning amplifies risk, especially in use cases where automation and credibility are vital and tightly coupled.

Ensuring AI is economically viable and socially valuable means we cannot rely on scaling. The dominant approach today prioritizes increasing compute and data while leaving the underlying reasoning machinery largely unchanged, a strategy that is becoming more expensive without becoming proportionally safer.

Related: Crypto dev launches website for agentic AI to ‘rent a human’

Advertisement

The alternative is architectural. Systems need to do more than predict the next word. They need to represent relationships, apply rules, check their own steps and make it possible to see how conclusions were reached.

This is where cognitive or neurosymbolic systems come into play. By organizing knowledge into interrelated concepts, rather than relying solely on brute-force pattern matching, these systems can deliver high reasoning capability with far lower energy and infrastructure demands.

Emerging “cognitive AI” platforms are demonstrating how structured reasoning systems can operate on local servers or edge devices, allowing users to keep control over their own knowledge rather than outsourcing cognition to distant infrastructure.

Cognitive AI systems are harder to design and can underperform on open-ended tasks, but when reasoning is reusable in this way rather than rederived from scratch through massive compute, costs fall and verification becomes tractable.

Advertisement

Control over how AI is built matters as much as how it reasons. Communities need systems they can shape, audit and deploy without waiting for permission from centralized platform owners.

Some platforms are exploring this frontier by using blockchain to enable both individuals and corporations to contribute data, models and computing resources. By decentralizing AI development itself, these approaches reduce concentration risk and align deployment with local needs rather than global demands.

AI faces an inflection point. When reasoning can be reused rather than rediscovered through massive pattern matching, systems require less compute per decision and impose a smaller verification burden on humans. That shifts the economics. Experimentation becomes cheaper, inference becomes more predictable. Scaling no longer depends on exponential increases in infrastructure.

Scaling has already done what it could. What it has exposed, just as clearly, is the limit relying on size alone. The question now is whether the industry keeps pushing scale or starts investing in architectures that make intelligence reliable before making it bigger.

Advertisement

Opinion by: Mohammed Marikar, co-founder at Neem Capital.